as a measure of extravascular lung water (EVLW)Instead of pulmonary artery wedge pressure (Ppaw) measurements to guide the hemodynamic management of 48 critically III patients. Patients _re randomized to either a protocol management (PM), or to a routine management (RM) group. In the RM group, EVLW measurements _re unknown to the primary care physicians. The 2 groups _re similar with respect to age, gender, and severity of Illness. In patients with Initially high EVLW,EVLW fell to a greater extent In PM than In RM patients (18 ± 5 versus 4 ± 8% decrease, p < 0.05). This difference was even greater in patients with heart failure. No adverse effects on oxygenation or renal function occurred In following the protocol. Mortality for the groups as a whole was similar, but was significantly better (p < 0.05) for PM patients with initially high EVLW and normal Ppaw (predominantly patients with sepsis or the adult respiratory distress syndrome). For both groups, patients with an Initial EVLW >14 ml/kg had a significantly greater mortality than did those with a lesser amount of EVLW:13 of 15 (87%) versus 13 of 32 (41%), P <0.0s. We conclude that management based on a protocol using EVLW measurements Is safe, may hasten the resolution of pulmonary edema, and may lead to improved outcome in some critically III patients.
Introduction
One rationale for pulmonary artery catheterization (PAC) in critically ill patientsisthat the hemodynamic information obtained often differs from that predicted byclinical evaluation alone (l, 2) . Even so, no study has ever explicitly shown that if hemodynamic parameters are used as end points for therapy, patient outcome is favorably altered (3) . Thus,it isquitepossible that PAC isoverused (3) .
Pulmonaryarterycatheterization isoften performedto obtain pulmonary artery occlusion or wedge pressure (Ppaw) measurements (4) (5) (6) , to guidefluidresuscitation during shock or diuretic therapy duringpulmonary edema. However, in many critically ill patients, Ppaw interpretation is difficult because of numerous potentialartifactsin the measurements (4) (5) (6) (7) . In suchcases, treatment basedon erroneous measurements could be hazardous.
An alternative approach might incorporate direct measurements of the extravascular watercontent of the lung as a therapeutic end point. Experimental and clinical studies (8) (9) (10) (11) have shown that the thermal green dye, doubleindicator dilution techniqueof measuringextravascular thermal volume (ETV) accurately reflects the quantity of extravascular lung water (EVLW). However, the technique has never beentested as an adjunct or alternative to the Ppaw measurement. Accordingly, we designed a prospective randomized studyto evaluate whetherEVLW could be safelyused as an end point for therapeuticintervention when PAC was performed for the diagnosis or management of hypotension or pulmonary edema. We comparedthe results of therapy in patients managed with a protocol based on EVLW measurements withthose of a control group of patients managed conventionally without knowledge of the EVLW value.
Methods

Conduct of the Study
Study eligibility was defined by hypotension 662 (systolic blood pressure <90 mm HG) prior to PAC, or after PAC if for any reason a Ppaw > 14 mm Hg was found. These criteria were arbitrarily selected since in our ICU in appropriate clinical circumstances, these values often represent threshold values for initiating therapy to either increase or decrease intravascular volume. Patients with an allergy to iodine-containing contrast material were excluded. In all cases, the attending and/or intensive care unit staff decided if PAC was clinically indicated. Then, after obtaining informed consent, patients wererandomized to either an EVLW protocol management (PM) or a routine management (RM) group. Treatment of PM patients was based on a specified algorithm that included EVLW measurements (figure 1). Treatment proceeded without regard to EVLWmeasurements in the RM group. The EVLW protocol mandated, in some instances, therapies that differed significantly from routine practices in our ICU. For example, if EVLW was normal, intravascular volume expansion was continued for hypotensive patients, even if the Ppaw was 18 mm Hg. On the other hand, if EVLW was abnormally elevated, intravascular volume expansion was restricted in hypotensive patients, even if the Ppaw was < 18 mm Hg.
Because of such departures from "conventional" or routine management, this initial study was specifically designed to exclude an adverse outcome caused by following the management protocol (seestatistical considerations, below).
In both groups, EVLW measurements were obtained on average every 6 to 8 h by one of a group of trained nurses. In the RM group, the nurse obtaining the EVLW measurement was not involved in the patient's care, and the measurement was kept from the physicians or nurses responsible for the patient's management. The EVLW measurements were obtained for 72 h (or less, if the clinical indication for PAC was no longer present, or if the patient died).
Each day, one of the investigators documented adherence to the EVLW treatment protocol in PM patients, and evaluated whether any adverse outcome had occurred because of the prescribed management. A physician not directly involved in the study was empowered to withdraw a patient from the EVLW protocol if in his judgment clinical progress was being adverselyaffected. This occurred only once among all 48 study patients. All fluid intake (including colloid, crystalloid, and blood products) and output (all sources, including dialysis losses) during the study wererecorded. Vital signs wererecorded according to ICU routine (usually every hour in hypotensive patients); routine laboratory tests, including hemoglobin/hematocrit and creatinine, were recorded at least on a daily • All abnormalities had to be newly present. > 60 mm Hg.
Each patient was followed for the duration of his hospitalization. In addition to the patient's final disposition, the number of days the patient received mechanical ventilation and supplemental oxygen were recorded. This study was approved by the institution's Human Studies Committee.
Measurement oj Lung Water and Other Hemodynamic Parameters
Extravascular thermal volume was measured by the thermal indocyanine green dye, doubleindicator dilution method (8), using a commercially available computer (Model 9310; Edwards Laboratories, Santa Ana, CAl. The value obtained was taken as equivalent to EVLW (8) . Indocyanine green dye injectate was prepared every 8 h and stored at 4 0 C on ice in the dark. All injections were made by hand after rapid transfer of the syringe from the icebath . A l-mg test dose of indocyanine green dye was injected intravenously prior to the first measurement. In the absence of any allergicreaction, the EVLWmeasurement was obtained with a fulllO-mg dose, and CO was determined simultaneously by the standard thermodilution technique. The value recorded for EVLW and CO was the average of at least 3 measurements that varied <20070.
No more than 5 measurements were made at one time. The EVLW values were expressed in milliliters per kilogram. We used 7 ml/kg as the upper limit of normal (11).
All pressure measurements, including Ppaw, weremade with fluid-filled transducers, zeroed and mechanically calibrated at the midthoracic level.Zero referenceleveland calibration were checked at least once per nursing shift (8 h) or when the patient's position changed. Pressures were recorded and read from wave forms made on a strip chart recorder. The Ppaw measurements weremade at end-expiration. No correction was made for levelsof positive end-expiratory pressure. All Ppaw tracings were kept and reviewed by one of the investigators for accuracy at a later time.
Chest Radiographs All chest radiographs wereobtained whenever possible with patients in the semierect position, using routine mobile unit radiography. Radiographs were interpreted by one of the investigators (DA) without knowledge of the patients' randomization or EVLW measurement. The radiographs weregraded on a fourpoint scale: 0 = no acute infiltrates to suggest an increased EVLW, 1 = pulmonary vascular redistribution and/or mild diffuse interstitial infiltrates, 2 = moderate diffuse interstitial infiltrate, 3 = diffuse interstitial and focal alveolar infiltrate, and 4 = diffuse alveolar infiltrate.
Estimation oj Severity oj Illness
Severity of illness (which might affect outcome independent of any hemodynamic management protocol) wasevaluated by summing the number of failed organ systemsupon entry to the study, and by determining the patient's health status prior to ICU admission. Criteria used to define organ system failure are given in table 1. Prior health status was graded on a four-point scale; 1 = no impairment, 2 = mild limitation of activity, 3 = severe restriction of activity, and 4 = bedridden or institutionalized. Both parameters have been shown to be of prognostic value in ICU patients (12) (13) (14) (15) .
Statistical Considerations and Methods
In deciding on study size, we estimated that 60% of patients would deteriorate regardless of therapy (including the protocol) (12, 13 On admission, approximately three quarters of patients in each group had an abnormally high EVLW (> 7.0 mllkg). In this subset, the initial EVLW was not significantly different between RM and PM groups (16.1 ± 1.9 versus 13.7 ± 1.2 mIl kg, p = NS) (figure 2). Interestingly, patients with EVLW > 7 ml/kg but a Ppaw < 18 mm Hg from both groups together (average Ppaw of 11.7 ± 1.1 mm Hg) had significantly greaterelevations of EVLW on entry into the study (16.9 ± 1.6ml/kg, n = 16) than did those with both elevatedEVLW and EVLW .. 7 ml/kg, Ppaw < 18 mmHg EVLW" 7 ml/kg, Ppaw~18 mmHg EVLW > 7 ml/kg, Ppaw < 18 mmHg EVLW > 7 ml/kg, Ppaw~18 mmHg EVLW .. 7 ml/kg EVLW > 7 ml/kg 
Initial EVLW Measurement versus Subsequent Management
To providesome objectiveevidencethat the protocol indeed resulted in different "
Radiographic and Hemodynamic Correlations
The correlationof the chestradiographic scorewithEVLW measurements isshown in figure 3 . Although 125 chest radiographs were obtained, only 85 were obtained within 4 h of an EVLW measurement. Our analysis, therefore, is limited to this subgroup. The lack of correlation between EVLW and chest radiographic interpretation is obvious from figure 3 . Therefore, we also separated the radiographs into 2 groups: clearly "normal"
(radiographic score = 0) and all other radiographs(scores 1to 4)and correlated them with a dichotomous analysis of EVLW (i.e., values greater or less than 7 ml/kg). Bythis analysis all radiographs were concordant with the EVLW measurement in 48010 of the patients (22 of 46), and all were discordant in 26010 (12 of 46). In 76010 (35 of 46), at least 1 radiographic interpretation wasconcordant with an EVLW measurement. As would be expected for this diverse group of patients with multiple etiologies for pulmonary edema, the correlation betweenEVLW and Ppaw measurements (n = 290) was poor (coefficient of determination = 0.026).
At the time of the first EVLW measurement, CO was similar for both groups(6.6 ± 3.0versus 5. 
Data are presented as the mean ± SEM. Statistical analysis included chi-square or Fisher's exact testanalyses for dichotomous variables, and paired or unpaired t-tests or analysis-of-variance techniques, asappropriate, forcontinuous variables. Correlations between variables were obtained by standard least-squares linear regression methods. Mortality and the number of days receiving mechanical ventilation were analyzed bylife tablemethods using a Cox multivariant analysis (16) that tookintoaccount the influence of age, priorhealth status, number of failed organ systems, andthepresence of hypotension on admission to the ICU on mortality. Statistical analysis was performed with the SAS statistical software system (SAS Institute, Cary, NC) using the facilities of the Washington University Biomedical Computing Laboratory.
Results
Patient Demographics
Forty-seven patientswere enteredintothe study,25 into the EVLW protocol group (PM) and 23 into the nonprotocol, i.e., routinelymanagedgroup (RM). One patient was admitted to the study on 2 different occasionsand wasrandomized once to each management group. For purposesof mortalitystatistics, however, she is consideredas part of her first randomization group (RM). A total of 351 EVLW measurements were made over99 patient-days. The2 groups(PM and RM) were not significantly different with respect to age, gender, prior health status, or number of failedorgan systems ( • • CHEST x·RAYSCORE Fig. 4 . Comparison of totalamountoffluid usedfor intravascular volume expansion (blood, colloids, or isotonic crystalloid solutions) during the first 24 h of therapyin patients with initiallyelevated extravascular lung water(EVLW). On average, morefluid wasgivento patients in the routinelymanaged group with an initially low wedgepressure (WP)than to comparable patients in the protocol-managed group, although the difference was not statistically significant.
Effect of EVLW Protocol on Short-Term Outcome
As already noted, despite relative fluid restriction in hypotensive PM patients, the number of patient daysthat pressors were requiredwasnot greaterin PM than in RM patients. In addition, the number of patients who developed an increased
Comparison of Mortality
Patients were followed in hospital for 18 ± 2 versus27 ± 6 days for the PM and RM groups, respectively. For both groups, there was a trend for the total number of failedorgan systems to be significantly related to the probability of Overall,46% (54% inhospital) of the patients managed using the EVLW protocoldiedinthe ICUcomparedwith65% (74% inhospital) of those managed conventionally(p = NS). The ICU mortality was similar in all hemodynamic subsets, exceptfor patients with an initially elevated EVLW but a Ppaw<18 mm Hg. Here only 33% (3 of 9) died in the protocol group (56% inhospital) compared with 100% (6of 6) ofthe conventionally managed patients (all in the ICU) (p < 0.05). This difference in mortality was also significant when life table analysis was employed (p = 0.036, Wilcoxan's rank test) (figure 5) evenaccounting for differences in age, number of failed organ systems, and prior health status. It is also apparent from this analysis (figure 5 ) that virtually the entire difference serum creatinineduring the study period was similar in the 2 groups (7 of 25 in the PM group versus 7 of 23 in the RM • group).
Oxygen and/or PEEP requirements changed to a similar degree during the : study period in both PM and RM patients. Overall,64% of the protocol pa-• tients and 78% of the conventionally treated patients werein respiratory failure on admission to the study. After the first day, improvements in oxygenation were similar for both groups, although the trend was for PM patients to do better than RM patients. By the end of the study, 36% of the patientsin the protocol group compared with 22% of the conventionally treated patients required either less supplemental oxygen or PEEP 
2000
' 000 ' 000 VOLUME 3000 ADMINISTERED Only 1 of the 7 patients in the PM group with a normal EVLW on admission had an elevatedEVLW by the conclusion of the study period; this patient never developed an elevated Ppaw. By comparison, 2 of 6 patients managed conventionally had an EVLW >7 mllkg by the conclusion of the study; in both cases,Ppaw also increasedabove 18 mm Hg. management for PM and RM patients, we compared the amount of fluid used for intravascularvolumeexpansion during the first 24 h of therapy in patients with an initial EVLW >7 ml/kg (35 of 48 patients) (figure 4). On average, less fluid was given to PM patients with a Ppaw < 18 mm Hg (treated primarily with vasopressors) than to similar patients in the RM group in the first 24 h (figure 4). Netfluid balance(allinput minus output) was similarlyreducedin the protocol patients (data not shown). Becauseof the smallnumberof patientsand the wide variability in amounts of fluid administered, this difference wasnot significant. One patient, who washypotensivewith an EVLW >7 mllkg on admission, was withdrawnfrom the protocol. This patient continued to receive fluids aggressively because of concomitant acute renal failure, which in the opinion of the responsible clinician might have responded to fluid administration. This patient, however, is still included in the PM group for any determination of outcome. Protocolpatientsreceived pressors for a shorter period of time (1.4 ± 0.1 days) than did patients managed routinely (2.9 ± 0.7 days), although this difference was not statistically significant.
The remainingpatients with EVLW > 7 mllkg had an initial Ppaw~18 mm Hg. As wouldbe expected (becauseboth EVLW and Ppaw were elevated), there was little difference in the amount of fluid used for intravascular volume expansion between hypotensive PM and RM patients (figure 4).
Effect of Management Protocol on Accumulation of EVLW
Bythe end of the study, EVLW decreased by 18 ± 5070 in PM patients with an initially elevated EVLW (> 7 mllkg), but by only 4 ± 8% in similar patients in the RM group (p <0.05) (figure 2). The EVLW did not changesignificantly in either group duringthe courseof the study in mortality in this subgroup became apparent during the first 72 h of treatment. Cardiac output also was similar in this subgroup, both at the outset of the study (6.4 ± 2.0 versus 5.9 ± 1.7 L/min, PM group versus RM group) and at the end of the study (5.9 ± 1.7 versus 5.7 ± 1.2 L/min, PM group versus RM group). Discussion Approximately 16 yr have passed since the introduction of PAC as a routine procedure for managing criticallyill patients. Despite frequent use, no study has ever specifically shown that using the information obtained by this procedure favorably affects patient outcome. Because a preceding clinicalevaluation often differs from the "objective" data obtained by PAC (1, 2), few clinicians have been willing to routinely treat critically ill patients without such information. Even so, the hazards of relying too heavily on data that are often of questionable validity are obvious (3) (4) (5) (6) .
We believe this to be the first study to prospectivelyevaluate the value of atherapeutic strategy based on measurements obtained during invasive hemodynamic monitoring. Wehypothesized that EVLW might be a better endpoint than Ppaw during the management of fluid resuscitation for shock or diuretic therapy for pulmonary edema. Five conclusions seem warranted from our data. (1)The EVLW measurement provides independent, clinically useful information from that obtained by Ppaw measurement or chest radiographic interpretation. (2) Following our protocol for hemodynamic management based on EVLW measurements is safe and can be ethically applied to a larger group of ICU patients. (3) Resolution of pulmonary edema may be more rapid when EVLW is used as a therapeutic endpoint (especially when the cause of pulmonary edema is congestive heart failure). (4) Prognosis of patients with extreme elevations in EVLW is significantly worse than for those with lesser increases. (5) Patient outcome might be improved by restricting excessive intravascular volume expansion in hypotensive patients with the adult respiratory distress syndrome (ARDS).
We found, as have others, that there is a poor correlation between chest radiographic interpretation or Ppaw and EVLW measurements (17) (18) (19) (20) . In our "real-life" clinical study, mobile unit radiography was hampered by performing studies with different x-ray units, along with inconsistencies in patient position. Furthermore, radiographic interpretation of pulmonary edema was hampered by the frequent occurrence of underlying lung disease or changes in ventilator settings. For these reasons, we did not find that adopting the criteria of Pistolesi and coworkers (21) improved our radiographic interpretation of pulmonary edema.
Because our study design included a treatment protocol that at times mandated a nonconventional approach to management, we made safety considerations paramount. It is important to point out that although fluids were restricted in some PM patients (i.e., patients with initially elevated EVLW and Ppaw < 18 mm Hg), these same patients were not hypovolemic, since their initial mean Ppaw was approximately 12 mm Hg. Thus, weare not advocating fluid restriction in hypotensive, hypovolemic patients. Furthermore, if PAC is already clinicallyindicated, obtaining the EVLW measurement itself provides little additional risk. To measure EVLW, a femoral arterial catheterization must be performed, but this procedure is also quite safe (22) and is routinely performed in most critically ill, hypotensive patients. In our study, there were no acute complications (e.g., serious bleeding, sepsis, arterial occlusion, or embolus) attributed· to femoral arterial catheterization per se. The EVLW measurement also carries a slight risk from potential adverse reactions to indocyanine green dye, but no such reactions wereobserved in our study, despite more than 350 measurements.
Of course, the safety of a protocol based on EVLW measurements depends in part of the accuracy of the measurement. The accuracy of the EVLW technique used in this study has been demonstrated in multiple experimental and clinical studies (8) (9) (10) (11) , in a wide variety of forms of pulmonary edema, and over a wide range of actual EVLWcontents. The technique may be inaccurate in certain forms of regional pulmonary edema, or when vascular obstruction is prominent (11, 23) . However, these factors do not seem to be important during most cases of diffuse pulmonary edema, as wereencountered in our study. Although a concern has been expressed that the EVLW measurement might paradoxically increase as perfusion to edematous areas improved during the resolution of pulmonary edema (11), we never noted this kind of disparity.
We believed that the greatest risk of our EVLW protocol was that we might cause or exacerbate pulmonary edema if intravascular volume expansion was continued when it might otherwise have been stopped, or that we might exacerbate renal failure by withholding fluids and using vasopressors when volume expan-sion might otherwise have been continued. Accordingly, we monitored effects on oxygenation by noting changes in F'I0 2 or PEEP to maintain the Pao, >60 mm Hg, and on renal function by monitoring the daily serum creatinine. Although other indices of oxygenation couldhave beenused,theyofferlittleadvantage when the F'Io 2 , PEEP, and hemodynamic state are being manipulated.We found no systematic difference for any outcome between the PM and RM groups as a whole. On the other hand, favorable trends were almost always inthe PM insteadof theRMgroup. Thus,we believe our conclusion concerning the safety of the EVLW protocol is reasonable and warranted.
The resolution of pulmonary edema was more rapid in patients managed by the EVLW protocol than in those managed byroutinemeasures (figure 2).
Thisdifference was greater stillin patients in whomboth EVLW and Ppawwere initiallyelevated (primarily patientsin congestive heart failure). This latter finding probably reflects continued aggressive diuretic therapy in the PM patients even after the WP fell below 18 mm Hg. On the other hand, whether outcome is affected (i,e., time receiving mechanical ventilation, duration of ICU stay, hospital duration, or mortality) by this shortened resolution time remains to be determined.
Our most strikingfinding was the improved survival of PM patients with initially elevated EVLW but a Ppaw < 18 mm Hg compared with patients in the RMgroup.Thisimprovement in survival persisted even after accounting for factors such as age, severity of illness, and primaryindicationfor PAC (figure 5)or cardiac output. It ispossible that patients in the nonprotocol group were actually more severely ill than those in the protocolgroup, despite our attemptsto demonstrateotherwise. In retrospect, the protocol patients in this subgroup required pressors for a shorter periodof timeand had a slightly lower initial EVLW than did PM patients, althoughneitherdifference was statistically significant. Other systems of quantitating severity of illness (14, 24, 25) mighthave revealed a differencebetween PM and RM patients, but these systems have never actually been testedfor usein studieslikeours. On the other hand, the reasonfor the difference in mortalityisnot clearsince wewere unable to demonstrate a difference in the response of EVLW or CO to protocol management during the first 24 to 48 h compared with routine management. However, several experimental studies (26-28) haveemphasized that measures (suchas fluid restriction) will minimize EVLW accumulation and it is possible that in a larger groupof patients, changes in EVLW would more closely relate to mortality.
It mightalso be arguedthat had "routine management" been different, our results would have beenless striking. For instance, in some ICUs, it may be common practice to use a lower target Ppaw than 18 rnmHg duringtherapy. Thistype of criticism begsthe question, however, since the goal of a study such as ours is to help define which approaches to management are optimal, and therefore which should become "routine".
Forthe studygroupas a whole, EVLW correlated poorlywithmortality, as noted by others (29) . However. mortality was significantly higher(87%)if EVLW was >14ml/kg than if EVLW waslessthan thisamount(41010). Thisfinding maysimplyreflect the poor prognosis of patients with ARDS or sepsis, since 87010 of patients with EVLW >14 mm Hg had one of theseadmitting diagnoses. The prognostic value of thisfinding, therefore, will require further study.
In summary, management based on EVLW measurements is safe, practical, and has been successfully applied in a group of critically ill ICU patients. Outcome is at least comparable to conventional approaches based on Ppaw measurements alone, and may be superior in selected patient subgroups. This study demonstrates the feasibility of performing studiesof this type, evenin critically ill leu patients. and can be used as a model for future studies.
